KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Total Current Liabilities (2016 - 2025)

Charles River Laboratories International has reported Total Current Liabilities over the past 17 years, most recently at $1.1 billion for Q4 2025.

  • For Q4 2025, Total Current Liabilities rose 12.7% year-over-year to $1.1 billion; the TTM value through Dec 2025 reached $1.1 billion, up 12.7%, while the annual FY2025 figure was $1.1 billion, 12.7% up from the prior year.
  • Total Current Liabilities for Q4 2025 was $1.1 billion at Charles River Laboratories International, roughly flat from $1.1 billion in the prior quarter.
  • Over five years, Total Current Liabilities peaked at $1.1 billion in Q3 2025 and troughed at $803.4 million in Q1 2021.
  • A 5-year average of $1.0 billion and a median of $1.0 billion in 2023 define the central range for Total Current Liabilities.
  • Biggest five-year swings in Total Current Liabilities: grew 27.7% in 2021 and later fell 5.96% in 2024.
  • Year by year, Total Current Liabilities stood at $1.0 billion in 2021, then increased by 5.65% to $1.1 billion in 2022, then decreased by 3.34% to $1.1 billion in 2023, then decreased by 5.78% to $994.1 million in 2024, then grew by 12.7% to $1.1 billion in 2025.
  • Business Quant data shows Total Current Liabilities for CRL at $1.1 billion in Q4 2025, $1.1 billion in Q3 2025, and $1.1 billion in Q2 2025.